Tetra Bio Pharma Inc TBPMQ

Healthcare Cannabis

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.

GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc

<< Previous

Bullboard Posts

Next >>

Post by SamV21on Apr 18, 2022 4:21pm

89 Views

Post# 34611240

Avicanna another winner 3.00 in 2019 to .285 today

Years of so much potenial and means so little without anything signed and NO PRODUCT TO SELL AFTER 4 YEARS OF REVENUE PROMISED , typical Guy , lets invent something get approval then sell it off for next to nothing to keep the doors open and make payments with shares from the company diluting it to death and the CEOs wages paid, then raise more money to pay another company to do our research, while CEO sits at home collecting 722,000 US through his privately held Inc. company .I would love to see that money trail and where it all comes from .Right hand paying the left hand and into his privately held Inc. company while shareholders suffer.

<< Previous

Bullboard Posts

Next >>

Tilray Brands seeks US$250M for U.S. cannabis expansion